Location: Los Angeles, CA
CIK: 0001389933 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 13, 2015
Total Value: $101M (93.1% shares, 6.9% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ATRC | ATRICURE INC | 487,946 | $10.69M | 10.6% | $11.85 | +110.9% | COM | 04963C209 |
| ABBV | ABBVIE INC | 116,581 | $6.343M | 6.3% | $42.33 | +0.4% | COM | 00287Y109 |
| — | NXSTAGE MEDICAL INC | 366,554 | $5.781M | 5.7% | $12.81 | — | COM | 67072V103 |
| — | ZS PHARMA INC | 66,194 | $4.346M | 4.3% | $46.38 | — | COM | 98979G105 |
| — | ACHILLION PHARMACEUTICALS | 480,300 | $3.319M | 3.3% | $10.22 | — | COM | 00448Q201 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 258,642 | $2.949M | 2.9% | $11.80 | +13.1% | COM | 09058V103 |
| — | AERIE PHARMACEUTICALS INC | 165,669 | $2.939M | 2.9% | $22.28 | — | COM | 00771V108 |
| — | BIOTELEMETRY INC | 235,645 | $2.884M | 2.9% | $9.68 | — | COM | 090672106 |
| PODD | INSULET CORP | 106,018 | $2.747M | 2.7% | $28.33 | +7.1% | COM | 45784P101 |
| — | RIGEL PHARMACEUTICALS INC | 1,109,740 | $2.741M | 2.7% | $2.69 | — | COM NEW | 766559603 |
| — | PROTALIX BIOTHERAPEUTICS INC | 4,000,000 | $2.698M | 2.7% | $0.80 | — | NOTE 4.500% 9/1 | 74365AAB7 |
| — | DISCOVERY LABORATORIES INC | 7,508,544 | $2.253M | 2.2% | $1.39 | — | COM NEW | 254668403 |
| — | INSULET CORP | 2,407,000 | $2.229M | 2.2% | $1.11 | — | NOTE 2.000% 6/1 | 45784PAD3 |
| — | APPLIED GENETIC TECHNOL CORP | 157,192 | $2.066M | 2.1% | $18.57 | — | COM | 03820J100 |
| — | OTONOMY INC | 111,466 | $1.985M | 2.0% | $28.54 | — | COM | 68906L105 |
| MASI | MASIMO CORPORATION | 46,010 | $1.774M | 1.8% | $23.74 | +72.2% | COM | 574795100 |
| — | DERMA SCIENCES INC | 356,918 | $1.681M | 1.7% | $12.78 | — | COM PAR $.01 | 249827502 |
| — | XENOPORT INC | 470,612 | $1.633M | 1.6% | $5.95 | — | COM | 98411C100 |
| — | SYNERGY PHARMACEUTICALS | 296,563 | $1.572M | 1.6% | $8.30 | — | COM | 871639308 |
| — | ESSA PHARMA INC | 228,500 | $1.424M | 1.4% | $5.69 | — | COM | 29668H104 |
| — | PROTALIX BIOTHERAPEUTICS INC | 1,193,189 | $1.408M | 1.4% | $4.41 | — | COM | 74365A101 |
| — | CYTRX CORP | 583,013 | $1.382M | 1.4% | $2.81 | — | COM PAR $.001 | 232828509 |
| — | CARA THERAPEUTICS INC | 93,574 | $1.337M | 1.3% | $12.15 | — | COM | 140755109 |
| — | NEOS THERAPEUTICS INC | 63,400 | $1.332M | 1.3% | $21.01 | — | COM ADDED | 64052L106 |
| STXS | STEREOTAXIS INC | 1,372,862 | $1.274M | 1.3% | $2.92 | -59.3% | COM NEW | 85916J409 |
| — | CELYAD | 30,000 | $1.256M | 1.2% | $52.03 | — | ADR | 151205200 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 140,600 | $1.159M | 1.2% | $8.24 | — | COM | 05337G107 |
| — | SCYNEXIS INC | 156,904 | $1.142M | 1.1% | $8.79 | — | COM | 811292101 |
| — | NOVADAQ TECHNOLOGIES INC | 101,841 | $1.062M | 1.1% | $13.46 | — | COM | 66987G102 |
| — | DICERNA PHARMACEUTICALS INC | 123,500 | $1.014M | 1.0% | $12.25 | — | COM | 253031108 |
| — | NUVASIVE INC | 760,000 | $959K | 1.0% | $0.99 | — | NOTE 2.750% 7/0 | 670704AC9 |
| ASND | ASCENDIS PHARMA | 53,241 | $942K | 0.9% | $17.35 | — | ADR | 04351P101 |
| — | SPECTRANETICS CORP | 79,812 | $941K | 0.9% | $15.23 | — | COM | 84760C107 |
| — | ZOGENIX INC | 68,900 | $930K | 0.9% | $1.68 | — | COM | 98978L204 |
| JNJ | JOHNSON AND JOHNSON | 9,400 | $877K | 0.9% | $59.66 | +21.5% | COM | 478160104 |
| — | VITAE PHARMACEUTICALS INC | 70,885 | $780K | 0.8% | $11.00 | — | COM | 92847N103 |
| — | INTEC PHARMA LTD | 135,000 | $756K | 0.8% | $5.60 | — | SHS ADDED | M53644106 |
| — | ABEONA THERAPEUTICS INC | 181,818 | $736K | 0.7% | $4.05 | — | COM | 00289Y107 |
| — | ARENA PHARMACEUTICALS INC | 381,600 | $729K | 0.7% | $3.26 | — | COM | 040047102 |
| QURE | UNIQURE B.V. | 35,000 | $716K | 0.7% | $15.53 | +69.5% | NV SHS | N90064101 |
| — | CYNAPSUS THERAPEUTICS INC | 44,824 | $707K | 0.7% | $18.24 | — | COM PAR NO PAR | 23257Y859 |
| — | AKARI THERAPEUTICS PLC | 26,390 | $633K | 0.6% | $23.99 | — | ADR ADDED | 00972G108 |
| — | SYNERON MEDICAL LTD | 85,947 | $615K | 0.6% | $8.70 | — | ORD SHS | M87245102 |
| — | ALDER BIOPHARMACEUTICALS INC | 18,000 | $590K | 0.6% | $32.78 | — | COM | 014339105 |
| — | REGULUS THERAPEUTICS INC | 90,000 | $589K | 0.6% | $6.54 | — | COM | 75915K101 |
| CDNA | CAREDX INC | 135,927 | $567K | 0.6% | $7.99 | -17.3% | COM | 14167L103 |
| — | CELGENE CORP | 5,200 | $562K | 0.6% | $108.08 | — | COM | 151020104 |
| GILD | GILEAD SCIENCES INC | 5,700 | $560K | 0.6% | $77.50 | 0.0% | COM | 375558103 |
| — | EXACTECH INC | 31,636 | $551K | 0.5% | $19.74 | — | COM | 30064E109 |
| — | IRONWOOD PHARMA | 600,000 | $537K | 0.5% | $0.96 | — | NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV | 46333XAC2 |
| — | CYNAPSUS THERAPEUTICS INC | 33,995 | $536K | 0.5% | $0.74 | — | COM | 23257Y156 |
| — | LIPOCINE INC | 45,000 | $532K | 0.5% | $8.58 | — | COM NEW | 53630X104 |
| — | TARGACEPT INC | 530,821 | $531K | 0.5% | $1.00 | — | NOTE 0.0% 19-Feb-2018 UNSECURED CONV | 87611RAA6 |
| — | DERMIRA INC | 22,500 | $525K | 0.5% | $17.55 | — | COM | 24983L104 |
| MGNX | MACROGENICS INC | 24,000 | $514K | 0.5% | $31.37 | 0.0% | COM | 556099109 |
| — | BLUEBIRD BIO INC | 6,000 | $513K | 0.5% | $35.88 | — | COM | 09609G100 |
| AMGN | AMGEN INC | 3,700 | $512K | 0.5% | $116.24 | 0.0% | COM | 031162100 |
| — | VTV THERAPEUTICS INC- CL A | 75,000 | $489K | 0.5% | $6.52 | — | CL A ADDED | 918385105 |
| — | TOBIRA THERAPEUTICS INC | 45,092 | $436K | 0.4% | $9.67 | — | COM | 88883P101 |
| — | COGENTIX MEDICAL INC | 351,781 | $436K | 0.4% | $1.68 | — | COM | 19243A104 |
| — | LUMENIS LTD | 31,072 | $430K | 0.4% | $9.19 | — | SHS CL B | M6778Q121 |
| — | INTERCEPT PHARMACEUTICALS IN | 2,430 | $403K | 0.4% | $149.37 | — | COM | 45845P108 |
| — | CARDICA INC | 1,402,762 | $379K | 0.4% | $1.12 | — | COM | 14141R101 |
| — | CATALYST BIOSCIENCES INC | 70,903 | $330K | 0.3% | $4.65 | — | COM ADDED | 14888D109 |
| — | TANDEM DIABETES CARE INC | 36,551 | $322K | 0.3% | $12.56 | — | COM | 875372104 |
| — | CHECK CAP LTD | 109,900 | $307K | 0.3% | $5.50 | — | SHS | M2361E112 |
| — | TENAX THERAPEUTICS INC | 81,509 | $245K | 0.2% | $3.01 | — | COM | 88032L100 |
| — | GENVEC INC | 95,800 | $221K | 0.2% | $2.37 | — | COM NEW | 37246C307 |
| XENE | XENON PHARMACEUTICALS INC | 25,000 | $207K | 0.2% | $9.93 | 0.0% | COM | 98420N105 |
| — | LOXO ONCOLOGY INC | 11,745 | $205K | 0.2% | $18.05 | — | COM | 548862101 |
| — | VENAXIS INC | 650,400 | $200K | 0.2% | $2.12 | — | COM | 92262A107 |
| — | NIVALIS THERAPEUTICS INC | 15,000 | $195K | 0.2% | $15.13 | — | COM | 65481J109 |
| — | MARINUS PHARMACEUTICALS INC | 22,319 | $186K | 0.2% | $11.60 | — | COM | 56854Q101 |
| — | PRONAI THERAPEUTICS INC | 8,500 | $174K | 0.2% | $20.47 | — | COM ADDED | 74346L101 |
| — | ACTINIUM PHARMACEUTICALS INC | 90,000 | $159K | 0.2% | $2.47 | — | COM | 00507W107 |
| — | TREVENA INC | 14,800 | $153K | 0.2% | $10.34 | — | COM | 89532E109 |
| — | ENTEROMEDICS INC | 500,000 | $130K | 0.1% | $0.26 | — | COM NEW | 29365M208 |
| — | CAS MEDICAL SYSTEMS INC | 86,768 | $108K | 0.1% | $1.34 | — | COM PAR $0.004 | 124769209 |
| — | ONCOTHYREON INC | 36,180 | $99,000 | 0.1% | $3.73 | — | COM | 682324108 |
| — | CHEMBIO DIAGNOSTICS INC | 21,722 | $88,000 | 0.1% | $3.37 | — | COM NEW | 163572209 |
| — | CEL SCI CORP | 139,500 | $84,000 | 0.1% | $0.66 | — | COM PAR $0.01 | 150837508 |
| — | APTOSE BIOSCIENCES INC | 19,239 | $83,000 | 0.1% | $5.20 | — | COM NEW | 03835T200 |
| — | CORBUS PHARMACEUTICALS HLDGS | 50,000 | $79,000 | 0.1% | $2.68 | — | COM | 21833P103 |
| — | ANTARES PHARMA INC | 45,000 | $77,000 | 0.1% | $2.09 | — | COM | 036642106 |
| GLPG | GALAPAGOS NV-SPON ADR | 1,709 | $70,000 | 0.1% | $40.96 | — | ADR | 36315X101 |
| — | ADVAXIS INC | 5,000 | $51,000 | 0.1% | $10.20 | — | COM NEW | 007624208 |
| — | GALMED PHARMACEUTICALS LTD | 5,871 | $44,000 | 0.0% | $7.49 | — | SHS | M47238106 |
| — | CHECK CAP LTD | 55,000 | $28,000 | 0.0% | $1.00 | — | *W EXP 02/28/202 | M2361E120 |